Through combined theoretical Monte Carlo stimulation and practical 31P Magnetisation Transfer Magnetic Resonance Spectroscopy we quantify the effects of 670 nm photobiomodulation treatment on healthy aging brains. Mitochondrial function declines with age and many pathological processes of neurodegenerative diseases stem from this mitochondrial dysfunction when they fail to produce the necessary energy required. Therefore, an aging population coupled with associated increases in cases of neurological conditions amplifies the need to develop safe, inexpensive treatments to restore mitochondrial function and offer neuronal protection as we grow old. Evidence shows that non-invasive transcranial red/infrared photobiomodulation (PBM) therapy can offer such neuroprotective benefits.
No takes yet. Share an insight, caveat, or question.
Fear et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: